Intracellular Targeted Drug Delivery Market Research Report - Segmented by Disease Type (Cardiovascular Diseases, Endocrine Diseases, Infectious Diseases, Oncological Disorders, Pulmonary Diseases); End User (Clinics, Hospitals, Others); and Region - Size, Share, Growth Analysis | Forecast (2024 – 2030)
Published: 2024 - January
Report Code: IM-15407
Format:
Region: Global
Chapter 1. Intracellular Targeted Drug Delivery Market – Scope & Methodology
1.1 Market Segmentation
1.2 Assumptions
1.3 Research Methodology
1.4 Primary Sources
1.5 Secondary Sources
Chapter 2. Intracellular Targeted Drug Delivery Market – Executive Summary
2.1 Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2 Key Trends & Insights
2.3 COVID19 Impact Analysis
2.3.1 Impact during 2023 – 2030
2.3.2 Impact on Supply – Demand
Chapter 3. Intracellular Targeted Drug Delivery Market – Competition Scenario
3.1 Market Share Analysis
3.2 Product Benchmarking
3.3 Competitive Strategy & Development Scenario
3.4 Competitive Pricing Analysis
3.5 Supplier Distributor Analysis
Chapter 4. Intracellular Targeted Drug Delivery Market Entry Scenario
4.1 Case Studies – Startup/Thriving Companies
4.2 Regulatory Scenario By Region
4.3 Customer Analysis
4.4 Porter's Five Force Model
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Powers of Customers
4.4.3 Threat of New Entrants
4.4.4 .Rivalry among Existing Players
4.4.5 Threat of Substitutes
Chapter 5. Intracellular Targeted Drug Delivery Market Landscape
5.1 Value Chain Analysis – Key Stakeholders Impact Analysis
5.2 Market Drivers
5.3 Market Restraints/Challenges
5.4 Market Opportunities
Chapter 6. Intracellular Targeted Drug Delivery Market - By Disease Type
6.1 Cardiovascular Diseases
6.2 Endocrine Diseases
6.3 Infectious Diseases
6.4 Oncological Disorders
6.5 Pulmonary Diseases
Chapter 7. Intracellular Targeted Drug Delivery Market - By End User
7.1 Clinics
7.2 Hospitals
7.3 Others
Chapter 8. Intracellular Targeted Drug Delivery Market – By Region
8.1 North America
8.2 Europe
8.3 AsiaPacific
8.4 Rest of the World
Chapter 9. Intracellular Targeted Drug Delivery Market - Key Players
9.1 Pfizer Inc. (United States)
9.2 AbbVie Inc. (United States)
9.3 Novartis AG (Switzerland)
9.4 Arrowhead Pharmaceuticals, Inc. (United States)
9.5 AstraZeneca PLC (United Kingdom)
9.6 ADC Therapeutics SA (Switzerland)
9.7 F. Hoffmann-La Roche AG (Switzerland)
9.8 Nanobiotix SA (France)
9.9 Seagen Inc. (United States)
9.10 CytImmune Sciences Inc. (United States)
Download Sample
Choose License Type
2850
5250
4500
1800
Frequently Asked Questions
Global Intracellular Targeted Drug Delivery Market is estimated to be worth USD 2.32 Billion in 2022 and is projected to reach a value of USD 7.87 Billion by 2030, growing at a CAGR of 16.5% during the forecast period 2023-2030.
The Global Intracellular Targeted Drug Delivery Market Drivers are the Rising Incidence of Chronic Diseases and the Growing Patient Preference for Advanced Healthcare Products.
Based on the Disease Type, the Global Intracellular Targeted Drug Delivery Market is segmented into Cardiovascular Diseases, Endocrine Diseases, Infectious Diseases, Oncological Disorders, and Pulmonary Diseases.
The United States is the most dominating country in the region of North America for the Global Intracellular Targeted Drug Delivery Market.
Pfizer Inc., AbbVie Inc., and Novartis AG are the leading players in the Global Intracellular Targeted Drug Delivery Market.
